About 31% of weight lost by adults during GLP-1 therapy comes from lean mass
Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled trial, according to findings published in Obesity. Researchers conducted a systematic review and meta-analysis of nine randomized controlled trials assessing exenatide (Byetta,